{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:46:13Z","timestamp":1792691173105,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Serine metabolism is a critical vulnerability in cancer; however, its role in mediating therapeutic resistance in non-small cell lung cancer (NSCLC) remains incompletely understood. In this study, we identify key enzymes in the serine synthesis pathway (SSP), namely PHGDH, PSAT1 and PSPH, as well as the serine transporter SLC1A4, which are significantly overexpressed in lung cancer and correlate with poor patient prognosis. We show that serine contributes to carboplatin resistance in NSCLC, particularly in lung squamous cell carcinoma (LUSC). Notably, the LUSC lineage-specific oncogene \u0394Np63\u03b1 serves as a master transcriptional regulator of serine biosynthesis, directly transactivating the expression of PHGDH, PSAT1, PSPH, and SLC1A4. \u0394Np63\u03b1-driven serine biosynthesis supports nucleotide synthesis and enhances antioxidant defense, enabling cancer cells to survive carboplatin-induced DNA damage and oxidative stress, thereby promoting therapeutic resistance. The combined inhibition of endogenous serine synthesis and restriction of exogenous serine\/glycine significantly overcomes \u0394Np63\u03b1-mediated carboplatin resistance. Our findings establish the \u0394Np63\u03b1-SSP axis as a critical mechanism driving carboplatin resistance in LUSC. These results highlight dual-targeted disruption of serine availability as a promising therapeutic strategy to overcome chemotherapy resistance in \u0394Np63\u03b1-driven LUSC. This study underscores the importance of lineage-specific metabolic dependencies as essential targets for precision oncology in NSCLC.<\/jats:p>","DOI":"10.1038\/s41419-026-08497-4","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:56:43Z","timestamp":1771333003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["\u0394Np63\u03b1 drives serine synthesis to promote carboplatin resistance in NSCLC"],"prefix":"10.1038","volume":"17","author":[{"given":"Liyuan","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruidong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8136-7442","authenticated-orcid":false,"given":"Hu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"8497_CR1","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.jtho.2020.04.028","volume":"15","author":"S Gao","year":"2020","unstructured":"Gao S, Li N, Wang S, Zhang F, Wei W, Li N, et al. Lung cancer in People\u2019s Republic of China. J Thorac Oncol. 2020;15:1567\u201376.","journal-title":"J Thorac Oncol"},{"key":"8497_CR2","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"8497_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398:535\u201354.","journal-title":"Lancet"},{"key":"8497_CR4","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1200\/JCO.21.01626","volume":"40","author":"AC Tan","year":"2022","unstructured":"Tan AC, Tan DSW. Targeted therapies for lung cancer patients with oncogenic driver molecular alterations. J Clin Oncol. 2022;40:611\u201325.","journal-title":"J Clin Oncol"},{"key":"8497_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1470-2045(15)00021-2","volume":"16","author":"N Thatcher","year":"2015","unstructured":"Thatcher N, Hirsch FR, Luft AV, Szczesna A, Ciuleanu TE, Dediu M, et al. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial. Lancet Oncol. 2015;16:763\u201374.","journal-title":"Lancet Oncol"},{"key":"8497_CR6","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","volume":"379","author":"L Paz-Ares","year":"2018","unstructured":"Paz-Ares L, Luft A, Vicente D, Tafreshi A, G\u00fcm\u00fc\u015f M, Mazi\u00e8res J, et al. Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer. N Engl J Med. 2018;379:2040\u201351.","journal-title":"N Engl J Med"},{"key":"8497_CR7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/jamaoncol.2021.0366","volume":"7","author":"J Wang","year":"2021","unstructured":"Wang J, Lu S, Yu X, Hu Y, Sun Y, Wang Z, et al. Tislelizumab plus chemotherapy vs chemotherapy alone as first-line treatment for advanced squamous non-small-cell lung cancer: a phase 3 randomized clinical trial. JAMA Oncol. 2021;7:709\u201317.","journal-title":"JAMA Oncol"},{"key":"8497_CR8","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.jtho.2021.04.011","volume":"16","author":"C Zhou","year":"2021","unstructured":"Zhou C, Wu L, Fan Y, Wang Z, Liu L, Chen G, et al. Sintilimab plus platinum and gemcitabine as first-line treatment for advanced or metastatic squamous NSCLC: results from a randomized, double-blind, phase 3 trial (ORIENT-12). J Thorac Oncol. 2021;16:1501\u201311.","journal-title":"J Thorac Oncol"},{"key":"8497_CR9","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1200\/EDBK_237829","volume":"39","author":"PK Paik","year":"2019","unstructured":"Paik PK, Pillai RN, Lathan CS, Velasco SA, Papadimitrakopoulou V. New treatment options in advanced squamous cell lung cancer. Am Soc Clin Oncol Educ Book. 2019;39:e198\u2013206.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"8497_CR10","doi-asserted-by":"crossref","unstructured":"Wang Y, Safi M, Hirsch FR, Lu S, Peters S, Govindan R et al. Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions. Nat Rev Clin Oncol. 2025;22:200\u201314.","DOI":"10.1038\/s41571-024-00979-8"},{"key":"8497_CR11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41568-022-00454-5","volume":"22","author":"M Labrie","year":"2022","unstructured":"Labrie M, Brugge JS, Mills GB, Zervantonakis IK. Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer. Nat Rev Cancer. 2022;22:323\u201339.","journal-title":"Nat Rev Cancer"},{"key":"8497_CR12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41580-019-0123-5","volume":"20","author":"J Zhu","year":"2019","unstructured":"Zhu J, Thompson CB. Metabolic regulation of cell growth and proliferation. Nat Rev Mol Cell Biol. 2019;20:436\u201350.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8497_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s42255-020-00329-9","volume":"3","author":"SL Geeraerts","year":"2021","unstructured":"Geeraerts SL, Heylen E, De Keersmaecker K, Kampen KR. The ins and outs of serine and glycine metabolism in cancer. Nat Metab. 2021;3:131\u201341.","journal-title":"Nat Metab"},{"key":"8497_CR14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.tcb.2017.05.001","volume":"27","author":"AC Newman","year":"2017","unstructured":"Newman AC, Maddocks ODK. Serine and functional metabolites in cancer. Trends Cell Biol. 2017;27:645\u201357.","journal-title":"Trends Cell Biol"},{"key":"8497_CR15","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.trecan.2021.06.004","volume":"7","author":"A Buqu\u00e9","year":"2021","unstructured":"Buqu\u00e9 A, Galluzzi L, Montrose DC. Targeting serine in cancer: is two better than one?. Trends Cancer. 2021;7:668\u201370.","journal-title":"Trends Cancer"},{"key":"8497_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drup.2012.07.002","volume":"15","author":"N Gonen","year":"2012","unstructured":"Gonen N, Assaraf YG. Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance. Drug Resist Updat. 2012;15:183\u2013210.","journal-title":"Drug Resist Updat"},{"key":"8497_CR17","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature11743","volume":"493","author":"OD Maddocks","year":"2013","unstructured":"Maddocks OD, Berkers CR, Mason SM, Zheng L, Blyth K, Gottlieb E, et al. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature. 2013;493:542\u201346.","journal-title":"Nature"},{"key":"8497_CR18","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1126\/science.1218595","volume":"336","author":"M Jain","year":"2012","unstructured":"Jain M, Nilsson R, Sharma S, Madhusudhan N, Kitami T, Souza AL, et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science. 2012;336:1040\u20134.","journal-title":"Science"},{"key":"8497_CR19","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nature11540","volume":"491","author":"B Chaneton","year":"2012","unstructured":"Chaneton B, Hillmann P, Zheng L, Martin ACL, Maddocks ODK, Chokkathukalam A, et al. Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature. 2012;491:458\u201362.","journal-title":"Nature"},{"key":"8497_CR20","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1073\/pnas.1204176109","volume":"109","author":"J Ye","year":"2012","unstructured":"Ye J, Mancuso A, Tong X, Ward PS, Fan J, Rabinowitz JD, et al. Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci USA. 2012;109:6904\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8497_CR21","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/ng.3421","volume":"47","author":"GM DeNicola","year":"2015","unstructured":"DeNicola GM, Chen PH, Mullarky E, Sudderth JA, Hu Z, Wu D, et al. NRF2 regulates serine biosynthesis in non-small cell lung cancer. Nat Genet. 2015;47:1475\u201381.","journal-title":"Nat Genet"},{"key":"8497_CR22","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cmet.2013.11.004","volume":"18","author":"J Ding","year":"2013","unstructured":"Ding J, Li T, Wang X, Zhao E, Choi JH, Yang L, et al. The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation. Cell Metab. 2013;18:896\u2013907.","journal-title":"Cell Metab"},{"key":"8497_CR23","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10350","volume":"476","author":"R Possemato","year":"2011","unstructured":"Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 2011;476:346\u201350.","journal-title":"Nature"},{"key":"8497_CR24","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/ng.890","volume":"43","author":"JW Locasale","year":"2011","unstructured":"Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet. 2011;43:869\u201374.","journal-title":"Nat Genet"},{"key":"8497_CR25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature22056","volume":"544","author":"ODK Maddocks","year":"2017","unstructured":"Maddocks ODK, Athineos D, Cheung EC, Lee P, Zhang T, van den Broek NJF, et al. Modulating the therapeutic response of tumours to dietary serine and glycine starvation. Nature. 2017;544:372\u20136.","journal-title":"Nature"},{"key":"8497_CR26","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.molcel.2016.04.033","volume":"62","author":"R Riscal","year":"2016","unstructured":"Riscal R, Schrepfer E, Arena G, Ciss\u00e9 MY, Bellvert F, Heuillet M, et al. Chromatin-bound MDM2 regulates serine metabolism and redox homeostasis independently of p53. Mol Cell. 2016;62:890\u2013902.","journal-title":"Mol Cell"},{"key":"8497_CR27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/cr.2015.33","volume":"25","author":"L Sun","year":"2015","unstructured":"Sun L, Song L, Wan Q, Wu G, Li X, Wang Y, et al. cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions. Cell Res. 2015;25:429\u201344.","journal-title":"Cell Res"},{"key":"8497_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1074\/jbc.M114.616359","volume":"290","author":"Y Ou","year":"2015","unstructured":"Ou Y, Wang SJ, Jiang L, Zheng B, Gu W. p53 Protein-mediated regulation of phosphoglycerate dehydrogenase (PHGDH) is crucial for the apoptotic response upon serine starvation. J Biol Chem. 2015;290:457\u201366.","journal-title":"J Biol Chem"},{"key":"8497_CR29","doi-asserted-by":"publisher","first-page":"7521","DOI":"10.1158\/0008-5472.CAN-14-2643-T","volume":"74","author":"SP Gravel","year":"2014","unstructured":"Gravel SP, Hulea L, Toban N, Birman E, Blouin MJ, Zakikhani M, et al. Serine deprivation enhances antineoplastic activity of biguanides. Cancer Res. 2014;74:7521\u201333.","journal-title":"Cancer Res"},{"key":"8497_CR30","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.cmet.2019.02.015","volume":"29","author":"MR Sullivan","year":"2019","unstructured":"Sullivan MR, Mattaini KR, Dennstedt EA, Nguyen AA, Sivanand S, Reilly MF, et al. Increased serine synthesis provides an advantage for tumors arising in tissues where serine levels are limiting. Cell Metab. 2019;29:1410\u201321.e1414.","journal-title":"Cell Metab"},{"key":"8497_CR31","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41586-020-2609-x","volume":"586","author":"T Muthusamy","year":"2020","unstructured":"Muthusamy T, Cordes T, Handzlik MK, You L, Lim EW, Gengatharan J, et al. Serine restriction alters sphingolipid diversity to constrain tumour growth. Nature. 2020;586:790\u20135.","journal-title":"Nature"},{"key":"8497_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s42255-020-0195-8","volume":"2","author":"A M\u00e9ndez-Lucas","year":"2020","unstructured":"M\u00e9ndez-Lucas A, Lin W, Driscoll PC, Legrave N, Novellasdemunt L, Xie C, et al. Identifying strategies to target the metabolic flexibility of tumours. Nat Metab. 2020;2:335\u201350.","journal-title":"Nat Metab"},{"key":"8497_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"8497_CR34","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1158\/1541-7786.MCR-19-0245","volume":"17","author":"AE Albert","year":"2019","unstructured":"Albert AE, Adua SJ, Cai WL, Arnal-Estap\u00e9 A, Cline GW, Liu Z, et al. Adaptive protein translation by the integrated stress response maintains the proliferative and migratory capacity of lung adenocarcinoma cells. Mol Cancer Res. 2019;17:2343\u201355.","journal-title":"Mol Cancer Res"},{"key":"8497_CR35","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333.","journal-title":"Science"},{"key":"8497_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20223-y","volume":"12","author":"M Tajan","year":"2021","unstructured":"Tajan M, Hennequart M, Cheung EC, Zani F, Hock AK, Legrave N, et al. Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy. Nat Commun. 2021;12:366.","journal-title":"Nat Commun"},{"key":"8497_CR37","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41418-024-01271-z","volume":"31","author":"H Chen","year":"2024","unstructured":"Chen H, Yu S, Ma R, Deng L, Yi Y, Niu M, et al. Hypoxia-activated XBP1s recruits HDAC2-EZH2 to engage epigenetic suppression of \u0394Np63\u03b1 expression and promote breast cancer metastasis independent of HIF1\u03b1. Cell Death Differ. 2024;31:447\u201359.","journal-title":"Cell Death Differ"},{"key":"8497_CR38","doi-asserted-by":"crossref","unstructured":"Zeng P, Sun S, Li R, Xiao ZX, Chen H. HER2 upregulates ATF4 to promote cell migration via activation of ZEB1 and downregulation of E-Cadherin. Int J Mol Sci. 2019;20:223.","DOI":"10.3390\/ijms20092223"},{"key":"8497_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07194-4","volume":"15","author":"J Tao","year":"2024","unstructured":"Tao J, Mao M, Lu Y, Deng L, Yu S, Zeng X, et al. \u0394Np63\u03b1 promotes radioresistance in esophageal squamous cell carcinoma through the PLEC-KEAP1-NRF2 feedback loop. Cell Death Dis. 2024;15:793.","journal-title":"Cell Death Dis"},{"key":"8497_CR40","doi-asserted-by":"publisher","first-page":"E3964","DOI":"10.1073\/pnas.1617816114","volume":"114","author":"L Hu","year":"2017","unstructured":"Hu L, Liang S, Chen H, Lv T, Wu J, Chen D, et al. \u0394Np63\u03b1 is a common inhibitory target in oncogenic PI3K\/Ras\/Her2-induced cell motility and tumor metastasis. Proc Natl Acad Sci USA. 2017;114:E3964\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8497_CR41","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.7150\/jca.87983","volume":"14","author":"Z Wu","year":"2023","unstructured":"Wu Z, Deng L, Tao J, Lu Y, Zeng X, Jia W, et al. CCT8 promotes cell migration and tumor metastasis in lung adenocarcinomas. J Cancer. 2023;14:3238\u201347.","journal-title":"J Cancer"},{"key":"8497_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07619-8","volume":"16","author":"H Wang","year":"2025","unstructured":"Wang H, Yang X, Deng L, Zhou X, Tao J, Wu Z, et al. ATF6\u03b1 inhibits \u0394Np63\u03b1 expression to promote breast cancer metastasis by the GRP78-AKT1-FOXO3a signaling. Cell Death Dis. 2025;16:289.","journal-title":"Cell Death Dis"},{"key":"8497_CR43","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrc3557","volume":"13","author":"JW Locasale","year":"2013","unstructured":"Locasale JW. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer. 2013;13:572\u201383.","journal-title":"Nat Rev Cancer"},{"key":"8497_CR44","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1158\/0008-5472.CAN-20-1541","volume":"81","author":"DC Montrose","year":"2021","unstructured":"Montrose DC, Saha S, Foronda M, McNally EM, Chen J, Zhou XK, et al. Exogenous and endogenous sources of serine contribute to colon cancer metabolism, growth, and resistance to 5-Fluorouracil. Cancer Res. 2021;81:2275\u201388.","journal-title":"Cancer Res"},{"key":"8497_CR45","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1096\/fj.201902690R","volume":"34","author":"L He","year":"2020","unstructured":"He L, Long J, Zhou X, Liu Y, Li T, Wu X. Serine is required for the maintenance of redox balance and proliferation in the intestine under oxidative stress. FASEB J. 2020;34:4702\u201317.","journal-title":"FASEB J"},{"key":"8497_CR46","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1007\/s00018-020-03539-2","volume":"77","author":"M Yi","year":"2020","unstructured":"Yi M, Tan Y, Wang L, Cai J, Li X, Zeng Z, et al. TP63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development. Cell Mol Life Sci. 2020;77:4325\u201346.","journal-title":"Cell Mol Life Sci"},{"key":"8497_CR47","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.18632\/aging.101725","volume":"10","author":"V Frezza","year":"2018","unstructured":"Frezza V, Fierro C, Gatti E, Peschiaroli A, Lena AM, Petruzzelli MA, et al. \u0394Np63 promotes IGF1 signalling through IRS1 in squamous cell carcinoma. Aging. 2018;10:4224\u201340.","journal-title":"Aging"},{"key":"8497_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41416-019-0464-z","volume":"121","author":"K Sellers","year":"2019","unstructured":"Sellers K, Allen TD, Bousamra M, Tan J 2nd, M\u00e9ndez-Lucas A, et al. Metabolic reprogramming and Notch activity distinguish between non-small cell lung cancer subtypes. Br J Cancer. 2019;121:51\u201364.","journal-title":"Br J Cancer"},{"key":"8497_CR49","doi-asserted-by":"crossref","unstructured":"Heylen E, Verstraete P, Van Aerschot L, Geeraerts SL, Venken T, Timcheva K et al. Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer. BrJ Cancer. 2023;128:1862\u201378.","DOI":"10.1038\/s41416-023-02216-y"},{"key":"8497_CR50","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s42255-023-00786-y","volume":"5","author":"YG Jeon","year":"2023","unstructured":"Jeon YG, Kim YY, Lee G, Kim JB. Physiological and pathological roles of lipogenesis. Nat Metab. 2023;5:735\u201359.","journal-title":"Nat Metab"},{"key":"8497_CR51","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.cmet.2020.02.017","volume":"31","author":"L Yang","year":"2020","unstructured":"Yang L, Garcia Canaveras JC, Chen Z, Wang L, Liang L, Jang C, et al. Serine catabolism feeds NADH when Respiration Is Impaired. Cell Metab. 2020;31:809\u201321.e806.","journal-title":"Cell Metab"},{"key":"8497_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/mog2.70005","volume":"3","author":"D Min","year":"2024","unstructured":"Min D, Jian Z, Max WS, Ming L. Redox regulation of cancer stem cells: biology and therapeutic implications. MedComm \u2012 Oncol. 2024;3:e70005.","journal-title":"MedComm \u2012 Oncol"},{"key":"8497_CR53","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1158\/1535-7163.MCT-16-0798","volume":"16","author":"KC Ross","year":"2017","unstructured":"Ross KC, Andrews AJ, Marion CD, Yen TJ, Bhattacharjee V. Identification of the serine biosynthesis pathway as a critical component of BRAF inhibitor resistance of melanoma, pancreatic, and non-small cell lung cancer cells. Mol Cancer Ther. 2017;16:1596\u2013609.","journal-title":"Mol Cancer Ther"},{"key":"8497_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55768-9","volume":"16","author":"Y Yi","year":"2025","unstructured":"Yi Y, Wang G, Zhang W, Yu S, Fei J, An T, et al. Mitochondrial-cytochrome c oxidase II promotes glutaminolysis to sustain tumor cell survival upon glucose deprivation. Nat Commun. 2025;16:212.","journal-title":"Nat Commun"},{"key":"8497_CR55","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1038\/onc.2013.456","volume":"33","author":"I Amelio","year":"2014","unstructured":"Amelio I, Markert EK, Rufini A, Antonov AV, Sayan BS, Tucci P, et al. p73 regulates serine biosynthesis in cancer. Oncogene. 2014;33:5039\u201346.","journal-title":"Oncogene"},{"key":"8497_CR56","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/1878-0261.12473","volume":"13","author":"V Gatti","year":"2019","unstructured":"Gatti V, Fierro C, Annicchiarico-Petruzzelli M, Melino G, Peschiaroli A. \u0394Np63 in squamous cell carcinoma: defining the oncogenic routes affecting epigenetic landscape and tumour microenvironment. Mol Oncol. 2019;13:981\u20131001.","journal-title":"Mol Oncol"},{"key":"8497_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-023-00426-1","volume":"18","author":"A Cappello","year":"2023","unstructured":"Cappello A, Tosetti G, Smirnov A, Ganini C, Yang X, Shi Y, et al. p63 orchestrates serine and one carbon metabolism enzymes expression in head and neck cancer. Biol Direct. 2023;18:73.","journal-title":"Biol Direct"},{"key":"8497_CR58","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.tcb.2022.08.003","volume":"33","author":"ML Fisher","year":"2023","unstructured":"Fisher ML, Balinth S, Mills AA. \u0394Np63\u03b1 in cancer: importance and therapeutic opportunities. Trends Cell Biol. 2023;33:280\u201392.","journal-title":"Trends Cell Biol"},{"key":"8497_CR59","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1016\/j.celrep.2017.11.030","volume":"21","author":"GX Wang","year":"2017","unstructured":"Wang GX, Tu HC, Dong Y, Skanderup AJ, Wang Y, Takeda S, et al. \u0394Np63 Inhibits oxidative stress-induced cell death, including ferroptosis, and cooperates with the BCL-2 family to promote clonogenic survival. Cell Rep. 2017;21:2926\u201339.","journal-title":"Cell Rep"},{"key":"8497_CR60","doi-asserted-by":"publisher","first-page":"7856","DOI":"10.1074\/jbc.M512655200","volume":"281","author":"W Yan","year":"2006","unstructured":"Yan W, Chen X. GPX2, a direct target of p63, inhibits oxidative stress-induced apoptosis in a p53-dependent manner. J Biol Chem. 2006;281:7856\u201362.","journal-title":"J Biol Chem"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08497-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08497-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08497-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T17:03:28Z","timestamp":1771520608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08497-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8497"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08497-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal care and experiments in this study were approved by the Institutional Animal Care and Use Committee (IACUC) of Chengdu Medical College, and the procedures were carried out according to the guidelines established by the China Council on Animal Care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"227"}}